Clinical Trial

Diffusion MRI in Cervical Spondylotic Myelopathy (CSM)

Study Description

Diffusion MRI in Cervical Spondylotic Myelopathy (CSM)

Patients who have been diagnosed with Cervical Spondylotic Myelopathy will be asked to undergo an MRI using diffusion basis spectrum imaging (DBSI) technology. The patients will have this MRI preoperatively and at 24 months postop. The investigators believe that with this imaging, biomarkers will be able to be seen to assist in prediction of long term outcomes in patients with spinal cord compression. These patients will be compared to healthy cohorts who will also undergo an MRI using the DBSI technology.

Location

Locations Selected Location

Methods

No pharmaceutical medication involved No pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Diagnostic Test - MRI with DBSI technology

The MRI will be done with diffusion basis spectrum imaging

Additional Information

Official Study Title

Predictive Value of Diffusion MRI in Cervical Spondylotic Myelopathy

Clinical Trial ID

NCT03296592

ParticipAid ID

1aMGQd